Scotland records 6.3% rise in revascularisation ops:
This article was originally published in Clinica
Executive Summary
Scotland has reported a significant rise in the number of revascularisation procedures. NHS Scotland performed 7,200 coronary artery bypass grafts and coronary angioplasties in 2004-05, which is up 6.3% annually, from 6,780. Cardiovascular and cerebrovascular health has improved, according to the latest diagnosis and coronary heart disease (CHD) and stroke (CVD) mortality rates. CHD mortality fell 7.3% across the general population between 2003 and 2004, to 139.4 per 100,000. Among the under-75s, the fall was 9.4%. The rate of new CHD diagnoses fell by 5.1% to 314 per 100,000. CVD mortality fell 6.2% over the same period, to 74.2 per 100,000 and 9.6% (to 22.5 per 100,000) among the under-75s. There was a 5.6% fall in the rate of new CVD diagnoses.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.